The value of B-type natriuretic peptide and big endothelin-1 for detection of severe pulmonary hypertension in heart transplant candidates

European Journal of Heart Failure

Volumn 7, Issue 7, 2005, Pages 1149-1155

  Kubánek, Miloš ^a   Málek, Ivan ^a   Kautzner, Josef ^a   Hegarová, Markéta ^a   Wiendl, Martin ^a   Lupínek, Petr ^a   Karasová, Ludmila ^a   Lánská, Věra ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

B type natriuretic peptide; Big endothelin 1; Congestive heart failure; Orthotopic heart transplantation; Pulmonary hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIG ENDOTHELIN 1; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HEART GRAFT; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MALE; POPULATION RESEARCH; PREDICTION; PRESSURE GRADIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PULMONARY HYPERTENSION; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; ENDOTHELIN-1; FEMALE; HEART CATHETERIZATION; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PULMONARY WEDGE PRESSURE; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 28344437149     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.12.011     Document Type: Article

References (39)

1. T. Tsutamoto, A. Wada, and K. Maeda Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
2. H. Yasue, M. Yoshimura, and H. Sumida Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
3. T.R. Porter, D.O. Taylor, and A. Cycan Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension J. Am. Coll. Cardiol. 22 1993 1418 1424
4. C.J. Cooper, F.W. Jevnikar, and T. Walsh The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure Am. J. Cardiol. 82 1998 609 614
5. D.L. Moraes, W.S. Colucci, and M.M. Givertz Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management Circulation 102 14 2000 1718 1723
6. G.A. Deuchar, A. Docherty, M.R. MacLean, and M.N. Hiks Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone Br. J. Pharmacol. 135 4 2002 1060 1068
7. L.E. Spieker, G. Noll, F.T. Ruschitzka, and T.F. Luscher Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for future? J. Am. Coll. Cardiol. 37 2001 1493 1505
8. J. Dupuis, D.J. Stewart, P. Cernacek, and G. Gosselin Human pulmonary circulation is an important site for both clearance and production of endothelin-1 Circulation 94 1996 1578 1584
9. S. Sakai, T. Miyauchi, and T. Sakurai Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist: increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats J. Am. Coll. Cardiol. 28 1996 1580 1588
10. A. Giaid, M. Yanagisawa, and D. Langleben Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N. Engl. J. Med. 328 1993 1732 1739
11. T. Tsutamoto, A. Wada, Y. Maeda, T. Adachi, and M. Kinoshita Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure J. Am. Coll. Cardiol. 23 1994 1427 1433
12. K. Stangl, T. Dschietzig, and C. Richter Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy Circulation 102 2000 1132 1138
13. R.J. Cody, G.J. Haas, P.F. Binkley, Q. Capers, and R. Kelley Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure Circulation 85 1992 504 509
14. R.J. Rodeheffer, A. Lerman, D.M. Heublein, and J.C. Burnett Increased plasma concentrations of endothelin in congestive heart failure in humans Mayo Clin. Proc. 67 1992 719 724
15. R. Pacher, B. Stanek, and M. Hulsmann Prognostic impact of big endothelin 1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure J. Am. Coll. Cardiol. 27 1996 633 641
16. C. Haug, W. Koenig, and M. Hoeher Direct enzyme immunometric measurement of plasma big endothelin-1 concentrations and correlation with indicators of left ventricular function Clin. Chem. 44 2 1998 239 243
17. A. Clerico, S. Ry, and D. Gianessi Measurement of cardiac natriuretic hormones in clinical practice Clin. Chem. 46 10 2000 1529 1540
18. G.A. Sagnella Measurement and importance of plasma brain natriuretic peptide and related peptides Ann. Clin. Biochem. 38 2 2001 83 92
19. J. Magga, M. Marttila, P. Mantymaa, O. Vuolteenaho, and H. Ruskoaho Brain natriuretic peptide in plasma, atria and ventricles of vasopresin- and phenylephrine-infused conscious rats Endocrinology 134 1994 1470 1473
20. H. Ruskoaho Cardiac hormones as diagnostic tools in heart failure Endocr. Rev. 24 2003 341 356
21. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, D.W. Mahoney, K.R. Bailey, and J.C. Burnett Plasma brain natriuretic peptide concentration: impact of age and gender J. Am. Coll. Cardiol. 40 2002 976 982
22. M. Hulsmann, B. Stanek, and B. Frey Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure J. Am. Coll. Cardiol. 32 1998 1695 1700
23. B. Stanek, B. Frey, E. Berger, E. Hartter, and R. Pacher Value of sequential big endothelin plasma concentrations to predict rapid worsening of chronic heart failure Transplant. Proc. 31 1999 155 157
24. B. Frey, R. Pacher, and G. Locker Prognostic value of hemodynamic vs big endothelin measurements during long-term iv therapy in advanced heart failure patients Chest 117 2000 1713 1719
25. L. Spinarova, J. Toman, J. Pospisilova, M. Soucek, T. Kara, and M. Stejfa Humoral response in patients with chronic heart failure Int. J. Cardiol. 65 1998 227 232
26. A. Lerman, R.J. Gibbons, and R.J. Rodeheffer Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction Lancet 341 1993 1105 1109
27. T.A. McDonagh, S.D. Robb, and D.R. Murdoch Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13
28. R.S. Vasan, E.J. Benjamin, and M.G. Larson Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction JAMA 2888 2002 1252 1259
29. O.W. Nielsen, T.A. Mc Donagh, S.D. Robb, and H.J. Dargie Retrospective analysis of the cost effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population J. Am. Coll. Cardiol. 41 2003 113 120
30. M.R. Cowie, A.D. Struthers, and D.A. Wood Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
31. D. Logeart, C. Saudubray, and P. Beyne Comparative value of doppler echocardiography and B type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea J. Am. Coll. Cardiol. 40 2002 1794 1800
32. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N. Engl. J. Med. 347 2002 161 167
33. A.S. Maisel, J. McCord, and R.M. Nowak Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction J. Am. Coll. Cardiol. 41 2003 2010 2018
34. K. Maeda, T. Tsutamoto, and A. Wada High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J. Am. Coll. Cardiol. 36 2000 1588 1593
35. V. Cheng, R. Kazanagra, and A. Garcia A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J. Am. Coll. Cardiol. 37 2001 386 391
36. D.R. Murdoch, T.A. Mc Donagh, J. Byrne, L. Blue, R. Farmer, and J.J. Morton Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored vs. empirical therapy Am. Heart J. 138 1999 1126 1132
37. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
38. R. Sodian, M. Loebe, and C. Schmitt Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems J. Am. Coll. Cardiol. 38 2001 1942 1948
39. J.W. Remme, and K. Swedberg Guidelines for the diagnosis and treatment of chronic heart failure Eur. Heart J. 22 2001 1527 1560